Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-02-23

Clinical Trial Update: Pharmacodynamic Study of TPN171H Tablets in Patients With Mild to Moderate Erectile Dysfunction [Phase 2]

View source ↗

Summary

Phase 2 pharmacodynamic study of TPN171H tablets in patients with erectile dysfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TPN171H tablets

Snippet

Sponsor: Vigonvita Life Sciences | Conditions: Erectile Dysfunction | Phase 2 | Status: COMPLETED